Related Experiment Videos
Acute zolpidem poisoning--analysis of 344 cases
R Garnier1, E Guerault, D Muzard
1Paris Poison Center, Hôpital Fernand-Widal, France.
Journal of Toxicology. Clinical Toxicology
|January 1, 1994
Summary
Acute Zolpidem overdose is generally benign, with most patients recovering rapidly. This hypnotic agent overdose rarely causes severe complications, confirming its safety profile in clinical practice.
Area of Science:
- Pharmacology
- Toxicology
- Clinical Medicine
Background:
- Zolpidem is a short-acting hypnotic agent introduced in 1988.
- Intentional acute overdoses present a clinical challenge for healthcare providers.
Purpose of the Study:
- To retrospectively review cases of intentional acute Zolpidem overdose.
- To evaluate the clinical presentation, management, and outcomes of Zolpidem overdose.
Main Methods:
- Retrospective analysis of 344 cases of intentional acute Zolpidem overdose.
- Review of patient demographics, ingested doses, co-ingestions, clinical signs, and therapeutic interventions.
Main Results:
- Most patients were female, aged 30-40 years, with 80% ingesting one pack or less.
- Two-thirds experienced intoxication signs, primarily drowsiness; severe outcomes like coma or respiratory failure were rare.
- 91% of patients showed rapid symptom remission; fatalities (6%) were not directly linked to Zolpidem.
Conclusions:
- Acute Zolpidem overdose is generally benign and self-limiting.
- Specific therapeutic measures are typically unnecessary, with supportive care often sufficient.
- Zolpidem overdose outcomes are favorable, reinforcing its safety profile in acute ingestions.